title: Early acute bioprosthetic valve failure associated with heparin-induced thrombocytopenia.
authors.forename: Mariana
authors.initials: M
authors.lastname: Floria
authors.forename: Alain
authors.initials: A
authors.lastname: Dive
authors.forename: Michel
authors.initials: M
authors.lastname: Buche
authors.forename: Baudouin
authors.initials: B
authors.lastname: Marchandise
authors.forename: Erwin
authors.initials: E
authors.lastname: Schroder
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects*; D001021:Aortic Valve / Q000601:surgery*; D001705:Bioprosthesis / Q000009:adverse effects*; D002442:Ceftazidime / Q000627:therapeutic use; D001026:Coronary Artery Bypass; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects* / Q000379:methods; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D018410:Pneumonia, Bacterial / Q000188:drug therapy / Q000209:etiology; D011475:Prosthesis Failure; D013921:Thrombocytopenia / Q000139:chemically induced*; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D014640:Vancomycin; D006493:Heparin; D002442:Ceftazidime